Santa Cruz Biotechnology features a diverse variety of CD175 monoclonal antibodies for advanced research in immunology and cell biology. CD175 monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD175, also known as the Lewis X antigen, plays a crucial role in cell adhesion and signaling, influencing processes such as immune response and tumor progression. CD175 expression is often associated with various pathological conditions, making it an important target for therapeutic interventions and diagnostic applications. Understanding CD175 function is essential for elucidating its role in disease mechanisms and developing targeted treatments. CD175 research continues to reveal new insights into cellular processes and disease pathways. Ongoing studies of CD175 contribute to the development of novel therapeutic strategies. Research utilizing CD175 monoclonal antibodies advances our understanding of immune system regulation and cancer biology. Santa Cruz Biotechnology monoclonal antibodies for CD175 support researchers worldwide in their pursuit of scientific discoveries and medical breakthroughs.